Form 4: Astronics Executive Boosts Stake via ESPP

Sentiment:

Insider Transaction Report 2 October 2025 4:22 PM

Astronics Corp. President of Test Systems, James Mulato, acquired 1,280 common shares through an employee stock purchase plan, increasing his direct beneficial ownership.

Summary

James Mulato, President of Astronics Test Systems, acquired 1,280 shares of Astronics Corp. common stock ($.01 PV Com Stk) at a price of $16.6 per share.
The transaction occurred on September 30, 2025, as part of an Employee Stock Purchase Plan (ESPP).
Following this transaction, Mulato directly beneficially owns 32,511.822 shares of common stock and 1,066 shares of Class B stock ($.01 PV CL B STK).
Mulato holds various stock options with exercise prices ranging from $9.74 to $35.61, with expiration dates extending up to December 7, 2033.
He also holds a target of 47,750 Restricted Stock Units (RSUs) across three grants, which are performance-based and vest contingent on Astronics Corp.'s average annual adjusted EBITDA over specific future periods.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive, even through a routine ESPP, generally signals a positive outlook and confidence in the company's future performance. The performance-based RSUs further align executive incentives with shareholder value creation.

Positives

An executive's acquisition of shares, even through an ESPP, can signal confidence in the company's future prospects and valuation.
The executive's compensation structure, including performance-based Restricted Stock Units, aligns management incentives with company financial performance (EBITDA targets).

Risks

The vesting of a significant portion of the executive's Restricted Stock Units (47,750 target units) is contingent on Astronics Corp.'s average annual adjusted EBITDA performance for periods ending December 31, 2025, December 31, 2026, and December 31, 2027. Failure to meet these performance targets could result in a lower vesting percentage (between 50% and 150% for some, 75% and 115% for others, of the target number).

Future Outlook

The executive's compensation structure includes performance-based Restricted Stock Units, with vesting contingent on Astronics Corp.'s average annual adjusted EBITDA performance for the periods spanning January 1, 2023, through December 31, 2027. This indicates a forward-looking incentive tied to future financial results.

Management Comments

James Mulato is the President of Astronics Test Systems.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an executive's acquisition of company stock through an Employee Stock Purchase Plan. Such filings provide transparency into management's direct ownership and compensation, which is standard practice across publicly traded companies in all industries.

Stakeholder Impact

Shareholders: Increased transparency regarding executive stock ownership and compensation structure. The insider purchase may be viewed as a positive signal of management confidence.
Employees: The Employee Stock Purchase Plan (ESPP) allows employees, including executives, to acquire company stock, fostering a sense of ownership and aligning interests.

Next Steps

Vesting of 11,500 target Restricted Stock Units on February 23, 2026, subject to 2023-2025 average annual adjusted EBITDA performance.
Vesting of 18,550 target Restricted Stock Units on February 22, 2027, subject to 2024-2026 average annual adjusted EBITDA performance.
Vesting of 17,700 target Restricted Stock Units on February 27, 2028, subject to 2025-2027 average annual adjusted EBITDA performance.

Key Dates

Date	Description
12/03/2016	Date options with an exercise price of $27.72 became exercisable.
12/14/2017	Date options with an exercise price of $31.76 became exercisable.
12/12/2018	Date options with an exercise price of $35.61 became exercisable.
12/13/2019	Date options with an exercise price of $31.57 became exercisable.
12/09/2020	Date options with an exercise price of $30.04 became exercisable.
01/22/2022	Date options with an exercise price of $14.45 became exercisable.
12/09/2022	Date options with an exercise price of $11.13 became exercisable.
12/16/2023	Date options with an exercise price of $9.74 became exercisable.
12/07/2024	Date options with an exercise price of $15.15 became exercisable.
09/30/2025	Date of common stock acquisition via Employee Stock Purchase Plan.
10/02/2025	Date the Form 4 was signed by Power of Attorney.
12/03/2025	Expiration date for options with an exercise price of $27.72.
February 23, 2026	Potential vesting date for 11,500 target Restricted Stock Units, contingent on 2023-2025 average annual adjusted EBITDA.
12/14/2026	Expiration date for options with an exercise price of $31.76.
February 22, 2027	Potential vesting date for 18,550 target Restricted Stock Units, contingent on 2024-2026 average annual adjusted EBITDA.
12/12/2027	Expiration date for options with an exercise price of $35.61.
February 27, 2028	Potential vesting date for 17,700 target Restricted Stock Units, contingent on 2025-2027 average annual adjusted EBITDA.
12/13/2028	Expiration date for options with an exercise price of $31.57.
12/09/2029	Expiration date for options with an exercise price of $30.04.
01/22/2031	Expiration date for options with an exercise price of $14.45.
12/09/2031	Expiration date for options with an exercise price of $11.13.
12/16/2032	Expiration date for options with an exercise price of $9.74.
12/07/2033	Expiration date for options with an exercise price of $15.15.

Recommendation

hold

While the insider acquisition of shares through an Employee Stock Purchase Plan (ESPP) by a key executive is a positive signal of confidence in the company's future, it is a routine transaction and not indicative of a significant strategic shift or extraordinary performance. Investors should consider this as a minor positive data point within a broader investment thesis, rather than a standalone reason for a strong buy or sell decision. The performance-based vesting of Restricted Stock Units (RSUs) tied to future EBITDA targets introduces a forward-looking element, but the immediate impact on valuation from this specific filing is limited.

Keywords

Astronics Corp, ATRO, Form 4, Insider Transaction, Employee Stock Purchase Plan, Executive Compensation, Stock Options, Restricted Stock Units, EBITDA Performance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.